Maternal Catecholamine Levels in Midpregnancy and Risk of Preterm Delivery
Overview
Authors
Affiliations
Associations between stress hormones and preterm delivery have not been fully explored. In this study, pregnant women enrolled from 52 clinics in 5 Michigan communities (1998-2004) provided urine samples for 3 days (waking and bedtime) during midpregnancy. Urinary catecholamine levels (epinephrine, norepinephrine, and dopamine) were measured in a subcohort (247 preterm and 760 term deliveries), and a 3-day median value was calculated. Polytomous logistic regression models assessed relations between catecholamine quartiles (of the median) and a 4-level outcome variable (i.e., term (referent) and 3 preterm delivery subtypes: spontaneous; premature rupture of membranes; and medically indicated). Final models incorporated other relevant covariates (e.g., creatinine, demographic, behavior). The risk of spontaneous preterm delivery was increased in the highest versus lowest quartile of norepinephrine and dopamine: norepinephrine, waking (adjusted odds ratio (AOR) = 3.7, 95% confidence interval (CI): 1.8, 7.9) and bedtime (AOR = 2.5, 95% CI: 1.3, 4.9); dopamine, waking (AOR = 2.6, 95% CI: 1.4, 5.1) and bedtime (AOR = 2.3, 95% CI: 1.2, 4.6). Adjusted odds ratios were further strengthened after removing women whose placentas showed evidence of acute infection or vascular pathology. High catecholamine levels in maternal urine may be indicative of excess stressors and/or predisposition to elevated sympathetic activation that contributes to increased risk of spontaneous preterm delivery.
Clinical considerations of emergent oral manifestations during pregnancy.
Zhang X, Liu X, Liu C, Hua C Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 42(2):142-153.
PMID: 38597074 PMC: 11034408. DOI: 10.7518/hxkq.2024.2023367.
Juvinao-Quintero D, Sanchez S, Workalemahu T, Pinto N, Liang L, Williams M medRxiv. 2023; .
PMID: 38045296 PMC: 10690348. DOI: 10.1101/2023.11.22.23298891.
Maternal Occupational Risk Factors and Preterm Birth: A Systematic Review and Meta-Analysis.
Adane H, Iles R, Boyle J, Gelaw A, Collie A Public Health Rev. 2023; 44:1606085.
PMID: 37937117 PMC: 10625911. DOI: 10.3389/phrs.2023.1606085.
Horackova H, Karahoda R, Vachalova V, Turkova H, Abad C, Staud F Sci Rep. 2022; 12(1):11603.
PMID: 35804076 PMC: 9270497. DOI: 10.1038/s41598-022-15790-7.
Zamani-Hank Y, Margerison C, Talge N, Holzman C Womens Health Rep (New Rochelle). 2022; 3(1):243-255.
PMID: 35262063 PMC: 8896219. DOI: 10.1089/whr.2021.0049.